Literature DB >> 17093957

[Diagnosis and clinical therapy for Parkinson's disease].

S Wenzel1, B Mollenhauer, C Trenkwalder.   

Abstract

For decades, awareness of Parkinson's disease mainly focused on the presence and treatment of motor symptoms. More and more other symptoms of this disease not related to the motor system now receive increased attention, including cognitive decline. Dementia in Parkinson's disease occurs more often than initially was thought. After an average of 8 years, about 40% of these patients suffer from cognitive decline. The difficulties and related problems affect prognosis more than do the motor symptoms. There is a need for standardized diagnostic and specific therapeutic intervention, but appropriate studies are still lacking.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17093957     DOI: 10.1007/s00115-006-2179-7

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  26 in total

1.  Parkinson's disease dementia--a first step?

Authors:  Daniel Z Press
Journal:  N Engl J Med       Date:  2004-12-09       Impact factor: 91.245

2.  Cognitive assessment of a representative community population with Parkinson's disease (PD) using the Cambridge Cognitive Assessment-Revised (CAMCOG-R).

Authors:  Richard J Athey; Robert W Porter; Richard W Walker
Journal:  Age Ageing       Date:  2005-05       Impact factor: 10.668

Review 3.  A systematic review of prevalence studies of dementia in Parkinson's disease.

Authors:  Dag Aarsland; Julia Zaccai; Carol Brayne
Journal:  Mov Disord       Date:  2005-10       Impact factor: 10.338

Review 4.  The Parkinson's complex: parkinsonism is just the tip of the iceberg.

Authors:  J William Langston
Journal:  Ann Neurol       Date:  2006-04       Impact factor: 10.422

5.  Tau protein, Abeta42 and S-100B protein in cerebrospinal fluid of patients with dementia with Lewy bodies.

Authors:  Brit Mollenhauer; Lukas Cepek; Mirko Bibl; Jens Wiltfang; Walter J Schulz-Schaeffer; Barbara Ciesielczyk; Manuela Neumann; Petra Steinacker; Hans A Kretzschmar; Sigrid Poser; Claudia Trenkwalder; Markus Otto
Journal:  Dement Geriatr Cogn Disord       Date:  2005-01-05       Impact factor: 2.959

6.  Alpha-synuclein pathology does not predict extrapyramidal symptoms or dementia.

Authors:  Laura Parkkinen; Tarja Kauppinen; Tuula Pirttilä; Jaana M Autere; Irina Alafuzoff
Journal:  Ann Neurol       Date:  2005-01       Impact factor: 10.422

7.  Cerebrospinal fluid markers in dementia with lewy bodies compared with Alzheimer disease.

Authors:  Estrella Gómez-Tortosa; Isabel Gonzalo; Samira Fanjul; Maria José Sainz; Susana Cantarero; Carlos Cemillán; Justo García Yébenes; Teodoro del Ser
Journal:  Arch Neurol       Date:  2003-09

8.  Alpha-synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma.

Authors:  Omar M A El-Agnaf; Sultan A Salem; Katerina E Paleologou; Leanne J Cooper; Nigel J Fullwood; Mark J Gibson; Martin D Curran; Jennifer A Court; David M A Mann; Shu-ichi Ikeda; Mark R Cookson; John Hardy; David Allsop
Journal:  FASEB J       Date:  2003-08-15       Impact factor: 5.191

Review 9.  Dementia associated with Parkinson's disease.

Authors:  Murat Emre
Journal:  Lancet Neurol       Date:  2003-04       Impact factor: 44.182

10.  Mortality in Parkinson's disease and its association with dementia and depression.

Authors:  T A Hughes; H F Ross; R H S Mindham; E G S Spokes
Journal:  Acta Neurol Scand       Date:  2004-08       Impact factor: 3.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.